Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 74.85M | 71.10M | 72.30M | 37.19M | 33.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.85M | 71.10M | 72.30M | 37.19M | 33.25M |
| Cost of Revenue | 63.65M | 64.86M | 64.81M | 61.84M | 58.77M |
| Gross Profit | 11.19M | 6.24M | 7.49M | -24.65M | -25.52M |
| SG&A Expenses | 19.99M | 19.78M | 19.61M | 18.80M | 18.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.64M | 84.64M | 84.42M | 80.64M | 76.77M |
| Operating Income | -8.80M | -13.55M | -12.12M | -43.45M | -43.52M |
| Income Before Tax | -42.00K | -6.38M | -6.12M | -38.62M | -39.04M |
| Income Tax Expenses | -- | -- | -- | -76.00K | -76.00K |
| Earnings from Continuing Operations | -0.04 | -6.38 | -6.12 | -38.55 | -38.96 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.00K | -6.38M | -6.12M | -38.55M | -38.96M |
| EBIT | -8.80M | -13.55M | -12.12M | -43.45M | -43.52M |
| EBITDA | -8.69M | -13.43M | -11.99M | -43.32M | -43.39M |
| EPS Basic | -0.16 | -1.29 | -1.93 | -4.81 | -5.60 |
| Normalized Basic EPS | -0.10 | -0.81 | -1.20 | -3.02 | -3.51 |
| EPS Diluted | -0.16 | -1.29 | -1.93 | -4.81 | -5.60 |
| Normalized Diluted EPS | -0.10 | -0.81 | -1.20 | -3.02 | -3.51 |
| Average Basic Shares Outstanding | 65.38M | 54.18M | 44.79M | 34.38M | 28.05M |
| Average Diluted Shares Outstanding | 65.38M | 54.18M | 44.79M | 34.38M | 28.05M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |